Bromocriptine quick-release as adjunct therapy in youth and adults with type 1 diabetes: A randomized, placebo-controlled crossover study.
Shoshana S TellMichal SchaferTimothy VigersAmy D BaumgartnerEllen LyonSusan GrossSarit PolskyJanet K Snell-BergeonIrene E SchauerKristen J NadeauPublished in: Diabetes, obesity & metabolism (2022)
Greater hyperglycaemia, insulin resistance, metabolic dysfunction and renal hyperfiltration in adolescents argues for increased attention during this high-risk age period. Although BCQR had little impact on glycaemia or insulin sensitivity, initial vascular and renal responses suggest potential benefits of BCQR in adolescents and adults with type 1 diabetes requiring further study.
Keyphrases
- young adults
- physical activity
- insulin resistance
- placebo controlled
- working memory
- metabolic syndrome
- adipose tissue
- type diabetes
- double blind
- mental health
- high fat diet
- oxidative stress
- randomized controlled trial
- skeletal muscle
- study protocol
- clinical trial
- stem cells
- mesenchymal stem cells
- climate change
- phase ii
- radiation therapy
- open label
- replacement therapy